Adam Asch to Treatment Outcome
This is a "connection" page, showing publications Adam Asch has written about Treatment Outcome.
Connection Strength
0.021
-
A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma. Br J Haematol. 2016 Oct; 175(2):281-289.
Score: 0.021